Amedisys Reports Second Quarter 2018 Financial Results and Updates 2018 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys (AMED) Tops Q2 EPS by 22c
July 31, 2018 4:17 PM EDTAmedisys (NASDAQ: AMED) reported Q2 EPS of $1.00, $0.22 better than the analyst estimate of $0.78. Revenue for the quarter came in at $411.6 million versus the consensus estimate of $403.62 million.
GUIDANCE:
Amedisys sees FY2018 EPS of $3.32-$3.41, versus the consensus of $3.10. Amedisys sees... More



